• Arts
  • Language Services
  • Furniture
  • Educational Services
  • Private Equity
  • Event Management
  • Nonprofit / Foundation
  • Manufacturing
  • Information Technology
  • Human Resources
  • Hotels and Restaurants
  • Health Care & Pharmaceuticals
  • Media - Broadcast and Publishing
  • Engineering / Construction
  • Food Products, Beverages and Tobacco
  • Petroleum Industry
  • Wholesale and Retail Trade
  • Travel and Leisure
  • Transporting, Moving and Warehousing
  • Telecommunications
  • Security Services
  • Real Estate
  • Marketing and Public Relations
  • Energy
  • Finance
  • Consumer Goods
  • Law Companies
  • Consultancy
  • Architecture
  • Airlines


Eversheds Sutherland acted for Hartenberg Capital on its divestiture of a minority stake and agreement with CVC Capital Partners for a co-controlling holding in FutureLife.

Company: Eversheds Sutherland, advokátní kancelář, s.r.o.

Eversheds Sutherland along with offices across our international firm are delighted to have acted for Hartenberg Capital on its minority stake divestiture and agreement (subject to regulatory approvals) with CVC Capital Partners for a co-controlling holding in FutureLife, a leading pan-European IVF provider.

Hartenberg Capital which was established in 2013 is a private equity firm based in Prague, Czech Republic, and our deal team was led by Michal Hrabovský in our Prague office along with Gavin O’Flaherty, a member of our healthcare M&A and private equity team out of our Dublin office.
The benefits of Eversheds Sutherland’s cross jurisdictional expertise were of particular relevance to this transaction as FutureLife, while also headquartered in Prague, is a leading Pan-European provider of IVF and related genetics services, with presence across eight European markets including Czech Republic, Ireland, Netherlands, Finland, United Kingdom, Romania, Slovakia and Estonia.
Our work began with the initial inception of the possible investment in mid-2021 when we assisted Lincoln International’s healthcare M&A team throughout the bid process and vendors due diligence up to the signing of transaction documents in December 2021 (subject to require regulatory approvals).
Jozef Janov of Hartenberg Capital said, “FutureLife is an exciting story that traces its roots back to an idea in 2013 to build a European IVF leader. FutureLife has since completed 22 acquisitions in eight countries including the recent acquisition of Nij Group in the Netherlands. At this stage in the development of the company and market, we believe it is the right time to take a new partner on board for FutureLife that can work alongside us. We consider CVC to be the right partner with whom we can accelerate towards our goal of becoming the largest and highest quality women’s health platform globally”.
Michal Hrabovský, Eversheds Sutherland Czech Republic, said, “This deal represents one of the largest transactions in the field of healthcare in the country's modern history. We are thankful to the team led by Jozef Janov for their trust and wish them every success in the further development of the FutureLife group, which already is the third largest IVF group in Europe”.
Gavin O’Flaherty, Eversheds Sutherland Ireland, said, ”This exciting, multi-jurisdictional transaction was a suitable way to finish off the year for our collective Eversheds Sutherland corporate team after such a strong year of private equity deal activity which also built on our ongoing pursuit of sectoral expertise including in the healthcare M&A and fertility sectors where we have historically acted for clients such as Virtus Healthcare. This sectoral expertise will be of all the more importance for discerning investors and buyers into the future”.
The Eversheds Sutherland deal team was led by Michal Hrabovský and Gavin O’Flaherty and they were supported by Marek Bomba, Michal Růžička, Ondřej Šudoma, Maroš Kandrík, Paulína Macháčová, Katarína Jendželovská, Jiří Brabec, Martina Vodičková, Karolina Rechtorovičová, Barbora Bugová, Jan Kohl, Petra Kratochvílová and Ondřej Beneš, Eversheds Sutherland Czech Republic, Steven Hacking, Rachel Lester, Meghan Bryson, Vanessa Challenger, Harry Taylor, Philip Crosbie and Aimee Southall, Eversheds Sutherland United Kingdom, Hannu Rintala, Petra Nieminen, Else Leppänen, Matti Jonkka and Fanny Pajuniemi, Eversheds Sutherland Finland, Cristian Lina, Carolina Baloleanu, Irina Stoicescu and Iulia Maria Moldovan, Eversheds Sutherland Romania, Maivi Ots, Kadri Kasepalu, Siim Olev, Marja-Stina Saaliste and Kristi Jõemets, Eversheds Sutherland Estonia, Bernhard Hager, Petra Marková, Jana Sapáková, Katarína Brath Liebscherová, Mária Sadloňová, Daša Derevjaniková and Filip Kozoň, Eversheds Sutherland Slovakia, and Sophie Dudley, Conor Bell, Michael Twomey, Sophie Delaney, Michelle Stewart and David McKeating, Eversheds Sutherland Ireland.
Read more here: https://bit.ly/3FnmT92

Gavin O´Flaherty
Eversheds Sutherland Ireland
Michal Hrabovský
Eversheds Sutherland Czech Republic

Tags: Law | Business Development | Awards & Achievements | Health |

AmCham Corporate Patrons



Are you sure? Do you really want to delete this item?